Relapsed glioblastomas respond to regorafenib

Relapsed glioblastomas respond to regorafenibRelapsed glioblastomas respond to regorafenib, Published online: 20 December 2018; doi:10.1038/s41571-018-0161-5Relapsed glioblastomas respond to regorafenib

https://www.nature.com/articles/s41571-018-0161-5

Source: Nature Clinical Practice Oncology - December 20, 2018 Category: Cancer & Oncology Authors: Peter Sidaway Source Type: research

More News: Cancer & Oncology